Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (opens new window)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Źródło‎: Crit Care Med 2009;37(4):1299-307.

Indeks‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (opens new window)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (opens new window)

Ball AM, Winstead PS.

Źródło‎: Pharmacotherapy 2008;28(11):1383-90.

Indeks‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (opens new window)

Reducing postburn injury anemia in a Jehovah's Witness patient. (opens new window)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Źródło‎: J Burn Care Res 2014;35(4):e258-61.

Indeks‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (opens new window)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (opens new window)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Źródło‎: Clin Ther 2008;30(12):2324-34.

Indeks‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (opens new window)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (opens new window)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Źródło‎: Transplant Proc 2015;47(8):2548-51.

Indeks‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (opens new window)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (opens new window)

Charles A, Purtill M, Napolitano LM.

Źródło‎: Anaesth Intensive Care 2006;34(6):793-6.

Indeks‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (opens new window)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (opens new window)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Źródło‎: Crit Care Med 1999;27(11):2346-50.

Indeks‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (opens new window)

Erythropoietin for critically ill trauma patients: a missed opportunity? (opens new window)

Corwin HL, Napolitano LM

Źródło‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Indeks‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (opens new window)

Postoperative management of severe acute anemia in a Jehovah's Witness. (opens new window)

de Araújo Azi LM, Lopes FM, Garcia LV

Źródło‎: Transfusion 2014;54(4):1153-7.

Indeks‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (opens new window)

Restrictive transfusion in geriatric trauma patients. (opens new window)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Źródło‎: Am Surg 2016;82(1):85-8.

Indeks‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (opens new window)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (opens new window)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Źródło‎: J Trauma 1998;44(2):361-7.

Indeks‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (opens new window)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (opens new window)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Źródło‎: Crit Care 2005;9(5):R508-15.

Indeks‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (opens new window)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (opens new window)

Hong T, Shander A, Agarwal S, Castresana M.

Źródło‎: A A Case Rep 2015;4(10):127-31.

Indeks‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (opens new window)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (opens new window)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Źródło‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

Indeks‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (opens new window)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (opens new window)

Lindholm J, Palmér K, Frenckner B.

Źródło‎: Perfusion 2012;27(4):332-4.

Indeks‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (opens new window)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (opens new window)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Źródło‎: Am Surg 2010;76(9):951-6.

Indeks‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (opens new window)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (opens new window)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Źródło‎: Intensive Care Med 2013;39(11):1896-908.

Indeks‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (opens new window)

Transfusion-free treatment strategies for acute anemia in critical care. (opens new window)

Morgan CA, Byul Sarah S, Forest CP.

Źródło‎: JAAPA 2016;29(8):38-44.

Indeks‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (opens new window)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (opens new window)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Źródło‎: J Trauma 2008;65(2):285-97.

Indeks‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (opens new window)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (opens new window)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Źródło‎: J Trauma 2009;67(1):121-4.

Indeks‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (opens new window)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (opens new window)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Źródło‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Indeks‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (opens new window)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (opens new window)

Posluszny JA Jr, Napolitano LM.

Źródło‎: Transfusion 2014;54(12):3026-34.

Indeks‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (opens new window)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (opens new window)

Price S, Pepper JR, Jaggar SI.

Źródło‎: Anesth Analg 2005;101(2):325-7.

Indeks‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (opens new window)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (opens new window)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Źródło‎: Am Surg 2015;81(6):e263-5.

Indeks‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (opens new window)

Erythropoietin response is blunted in critically ill patients. (opens new window)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Źródło‎: Intensive Care Med 1997;23(2):159-62.

Indeks‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (opens new window)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (opens new window)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Źródło‎: Br J Anaesth 2005;94(4):442-4.

Indeks‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (opens new window)

Management of anemia in patients who decline blood transfusion. (opens new window)

Shander A, Goodnough LT

Źródło‎: Am J Hematol 2018;93(9):1183-91.

Indeks‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (opens new window)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (opens new window)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Źródło‎: Arch Surg 2012;147(3):251-5.

Indeks‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (opens new window)

Intravenous iron following cardiac surgery does not increase the infection rate. (opens new window)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Źródło‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Indeks‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (opens new window)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (opens new window)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Źródło‎: Crit Care 2015;19:49.

Indeks‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (opens new window)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (opens new window)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Źródło‎: Crit Care Med 2024;52(4):618-25.

Indeks‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (opens new window)